Cloning, Expression and Pharmacological Characterization of a Human Glutamate Receptor: HGluR4
Overview
Affiliations
A member of the ionotropic family of glutamate receptors, hGluR4, was isolated from a human cDNA library and characterized following expression in mammalian cell lines. Human GluR4 possessed a 99% amino acid and 92% nucleotide homology to that of its rat counterpart with sequence differences restricted to the carboxy and amino terminal regions of the molecule. Transfection of simian kidney cells (COS-1) with an hGluR4 expression plasmid resulted in the transient formation of a membrane protein that possessed high specific binding for [3H](RS)-alpha-amino- 3-hydroxy-5-methylisoxazole-4-propionic acid ([3H]AMPA) but not [3H]kainate. Competition studies yielded a displacement profile of AMPA = quisqualate > glutamate > domoate > kainate >> N-methyl-D-aspartate (NMDA) or dihydrokainate. Whole-cell, voltage-clamp recordings from a human embryonic kidney cell line (HEK 293) stably expressing hGluR4 confirmed the presence of constitutively active, ligand-gated ion channels activated by AMPA, glutamate and kainate but not N-methyl-D-aspartate. Kainate-evoked currents were reversibly attenuated by 6-cyano-7-nitro- quinoxaline-2,3-dione (CNQX) but not DL-2-amino-5- phosphonovalerate (DL-AP5). Agonist-evoked currents exhibited inward rectification and ion substitution experiments indicated that hGluR4 receptor-linked ion channels in their homomeric state are permeable to both CA2+ and Na+ ions. In the same cell line antibody to rat GluR4 immunoprecipitated a major protein band at approximately 108 kDa and a minor one at approximately 340 kDa. The immunoblot analysis of membranes chemically crosslinked with dithiobis(succinimidylpropionate) showed a broad band at 550-600 kDa suggesting that the GluR4 receptor forms a pentamer in situ. This is the first report of the cloning of hGluR4 receptor and its stable expression in a human cell line.
TAK-137, an AMPA-R potentiator with little agonistic effect, has a wide therapeutic window.
Kunugi A, Tanaka M, Suzuki A, Tajima Y, Suzuki N, Suzuki M Neuropsychopharmacology. 2018; 44(5):961-970.
PMID: 30209408 PMC: 6461786. DOI: 10.1038/s41386-018-0213-7.
Glutamate receptors in neuroinflammatory demyelinating disease.
Bolton C, Paul C Mediators Inflamm. 2006; 2006(2):93684.
PMID: 16883070 PMC: 1592583. DOI: 10.1155/MI/2006/93684.
Multiple molecular determinants for allosteric modulation of alternatively spliced AMPA receptors.
Quirk J, Nisenbaum E J Neurosci. 2003; 23(34):10953-62.
PMID: 14645491 PMC: 6740967.
Seneci P, Miertus S Mol Divers. 2002; 5(2):75-89.
PMID: 11865648 DOI: 10.1023/a:1013824317218.